Search

Author/Creator Verheij, Marcel

11. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. (June 2020)

Authors:
van der Heijden, Martijn; Essers, Paul B.M.; Verhagen, Caroline V.M.; Willems, Stefan M.; Sanders, Joyce; de Roest, Reinout H.; Vossen, David M.; Leemans, C. René; Verheij, Marcel; Brakenhoff, Ruud H.; van den Brekel, Michiel W.M.; Vens, Conchita
Journal:
Radiotherapy and oncology
Issue:
Volume 147(2020)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignancies. (November 2021)

Authors:
Valentini, Vincenzo; Cellini, Francesco; Riddell, Angela; Brunner, Thomas B.; Roeder, Falk; Giuliante, Felice; Alfieri, Sergio; Manfredi, Riccardo; Ardito, Francesco; Fiorillo, Claudio; Porziella, Venanzio; Morganti, Alessio G.; Haustermans, Karin; Margaritora, Stefano; De Bari, Berardino; Matzin...
Journal:
Radiotherapy and oncology
Issue:
Volume 164(2021)
Page Start:
92
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells. Issue 3 (September 2015)

Authors:
Verhagen, Caroline V.M.; de Haan, Rosemarie; Hageman, Floor; Oostendorp, Tim P.D.; Carli, Annalisa L.E.; O'Connor, Mark J.; Jonkers, Jos; Verheij, Marcel; van den Brekel, Michiel W.; Vens, Conchita
Journal:
Radiotherapy and oncology
Issue:
Volume 116:Issue 3(2015:Sep.)
Page Start:
358
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. (January 2020)

Authors:
Elbers, Joris B.W.; Al-Mamgani, Abrahim; Tesseslaar, Margot E.T.; van den Brekel, Michiel W.M.; Lange, Charlotte A.H.; van der Wal, Jacqueline E.; Verheij, Marcel; Zuur, Charlotte L.; de Boer, Jan Paul
Journal:
Radiotherapy and oncology
Issue:
Volume 142(2020)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials. Issue 3 (March 2018)

Authors:
de Haan, Rosemarie; Pluim, Dick; van Triest, Baukelien; van den Heuvel, Michel; Peulen, Heike; van Berlo, Damien; George, Jay; Verheij, Marcel; Schellens, Jan H.M.; Vens, Conchita
Journal:
Radiotherapy and oncology
Issue:
Volume 126:Issue 3(2018)
Page Start:
443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Late follow‐up of the randomized radiation and concomitant high‐dose intra‐arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer. (6th July 2015)

Authors:
Heukelom, Jolien; Lopez–Yurda, Marta; Balm, Alfons J. M.; Wijers, Oda B.; Buter, Jan; Gregor, Theo; Wiggenraad, Ruud; de Boer, Jan Paul; Tan, I. Bing; Verheij, Marcel; Sonke, Jan‐Jakob; Rasch, Coen R.
Journal:
Head & neck
Issue:
Volume 38(2016)Supplement 1
Page Start:
E488
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗